South Dakota · 2025 Regular Session · Bill

SB 154: prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor.

Enacted Last action March 13, 2025: Signed by the Governor on 2025-03-13 S.J. 528

Plain-language summary

SB 154 is a bill introduced in the South Dakota Senate on January 30, 2025. According to its official title, it concerns: prohibit pharmaceutical manufacturers from interfering in contracts between 340B entities and pharmacies and to provide a penalty therefor. Primary sponsor: Kadyn Wittman (Democratic), Glen Vilhauer (Republican), Jamie Smith (Democratic), Stephanie Sauder (Republican), Matt Roby (Republican), Carl Perry (Republican), Erik Muckey (Democratic), Scott Moore (Republican), Eric Emery (Democratic), Taylor Rehfeldt (Republican), Tim Reed (Republican). Most recent recorded action (March 13, 2025): Signed by the Governor on 2025-03-13 S.J. 528.

Sponsors

Primary sponsors: Kadyn Wittman (Democratic); Glen Vilhauer (Republican); Jamie Smith (Democratic); Stephanie Sauder (Republican); and 7 more.